Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Ifetroban by Cumberland Pharmaceuticals for Idiopathic Pulmonary Fibrosis: Likelihood of Approval
Ifetroban is under clinical development by Cumberland Pharmaceuticals and currently in Phase II for Idiopathic Pulmonary Fibrosis. According to GlobalData,...
Data Insights
Ifetroban by Cumberland Pharmaceuticals for Asthma: Likelihood of Approval
Ifetroban is under clinical development by Cumberland Pharmaceuticals and currently in Phase II for Asthma. According to GlobalData, Phase II...